Perspective · 29 Oct 2023
Conference abstractPublished 20 Apr 2018
Drug resistant Tuberculosis-challenges unfolded
B J Govt. Medical College, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Antibiotic resistance is an important concern for the public health authorities at global level. Community based researches in developing countries have shown increase in burden of antimicrobial resistance. In 1993, World Health Organization (WHO) declared Tuberculosis as a global emergency and promoted directly observed treatment short course (DOTS) in 1995. Millions of lives have been saved compare with the pre-DOTS era, high cure rates have been achieved in most of countries worldwide. Global incidence of tuberculosis has been in a slow decline since the early 2000âÂ?Â?s. However, the emergence and spread of Multidrug resistant (MDR) tuberculosis, extensively drug resistant (XDR) tuberculosis pose a threat to global tuberculosis control. Genotypic and phenotypic changes in Mycobacterium tuberculosis, with lack of adequate laboratory facilities in most of tuberculosis endemic countries leads to missing the diagnosis. Multidrug resistant tuberculosis and XDR tuberculosis greatly complicate patient management within resource poor national tuberculosis program, reducing treatment efficacy and increasing the cost of treatment. Despite, nearly 20 years of WHO promoting activity and >12 years of MDR tuberculosis specific activity, has the country response to the drug resistant tuberculosis epidemic been so in effectual? The current dilemmas, challenges and priority needs for global drug resistance screening and surveillance, improving treatment regimens, and management of outcomes and prevention of drug resistance will be discussed.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 10 Apr 2023
Tuberculosis Drug Resistance, Risk Factors and Treatment
Short communication · 18 Jan 2023
Treatment of Drug Resistant Tuberculosis: A Global Feasibility Study
Conference abstract · 25 Apr 2022
Adverse effects of among multi drug resistance tuberculosis patients in Malawi
Short communication · 5 Aug 2021
Distribution of multiple-drug resistant (MDR) tuberculosis among HIV sero-positive and sero- negative populations in Ilorin, North-Central Nigeria
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
How is really working adaptive immune system in mammals? A novel conception and reverse pathway theory, which will bring novel multibillion super-antibody (sab) technology for curing of all of infectious diseases and cancer!
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rahul M Lokhande”

